Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$4.65 - $7.23 $84,630 - $131,586
-18,200 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$7.41 - $10.99 $134,862 - $200,018
18,200 New
18,200 $139,000
Q1 2021

May 17, 2021

SELL
$7.03 - $16.51 $29,526 - $69,342
-4,200 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$5.76 - $11.95 $24,192 - $50,190
4,200 New
4,200 $29,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.